As professional football grapples with evolving attitudes toward cannabis, the NFL and the NFL Players Association (NFLPA) are reportedly considering additional refinements to the league’s cannabis testing regime. While sweeping changes were agreed upon in December 2024, sources suggest further adjustments remain under discussion—particularly around thresholds, transparency, and discipline.

Recent Revisions: A Softer Stance

In late 2024, the NFL and NFLPA announced a significant loosening of the league’s substance-abuse policy regarding THC. Among the most consequential shifts: the threshold for a positive cannabis test was raised from 150 ng/mL to 350 ng/mL, and penalties for first and second positive tests were replaced with fixed fines of $15,000 and $20,000, respectively—instead of writing off portions of salary tied to game checks. Teams will no longer be informed of the precise substance behind a positive test, receiving only notice of the infraction and penalty. Additionally, counting of missed and positive test offenses now resets after one year with no violations.

These changes built on an earlier 2020 collective bargaining agreement that eliminated suspensions for positive cannabis tests and narrowed the testing window to a brief preseason interval.

Even so, lingering tensions remain about how far reforms should go.

Possible Further Revisions: What’s on the Table

According to insiders briefed on the matter, the NFL and NFLPA are exploring continued modifications. Some of the potential areas under debate include:

• Further raising or eliminating THC thresholds: Given the wide variance in how THC is metabolized, there is pressure to adopt a more lenient or even non-threshold policy for cannabis, especially in states where recreational use is legal.
• Treatment- vs. punishment-based responses: Advocates argue for substituting fines with counseling or wellness-based programs, especially for first-time positives.
• Greater privacy and anonymized handling: Beyond withholding the substance in question, more stringent protections for player medical information may be considered.
• Revisiting the testing window: Expanding or shifting the period during which players are subject to cannabis testing is another possibility under discussion.
• Addressing disparities across states: As more states legalize cannabis, the league may consider carving out special rules for players in those jurisdictions or modifying enforcement accordingly.

One contentious point involves whether players who use medical cannabis (where legal) should be exempt, or be granted safe harbor protections, from sanctions — a concept that has gained traction in other sports leagues.

Stakeholder Perspectives

Player advocates point out that many athletes already use cannabis, both recreationally and for pain or anxiety management. Former players like Eugene Monroe continue to be vocal proponents of full decriminalization or removal of THC from the banned substances list. They emphasize that the current penalties still can stigmatize players and create adversarial dynamics between the league and its athletes.

On the other hand, the NFL has maintained that it must balance medical and wellness concerns against integrity and safety. In its 2024 policy memo, the league reaffirmed that it views THC as a risk for “on-field injuries, diminished performance, [and] alienation of the fans.” The NFL also introduced discretionary testing for fentanyl (with no sanction for a positive result, but fines tied to skipping required meetings) in the same policy reform.

Some sports observers also caution that completely relaxing testing may create reform backlash, especially if it is perceived to conflict with anti-drug norms in professional sport.

What’s Next and Why It Matters

Any further amendments would likely emerge during upcoming collective bargaining talks or through side agreements between the league and the NFLPA. Given the shifting public sentiment toward cannabis, the league’s desire to modernize its image, and players’ calls for fairness, momentum exists behind additional reform.

The stakes are significant. How the NFL handles cannabis could set precedents for other major sports leagues still wrestling with similar pressures. A more permissive approach might reduce tension between players and the league, lessen administrative burdens, and reflect evolving norms around cannabis. On the flip side, critics worry about consistency, player health, and undermining the discipline framework.

For now, the 2024 changes mark meaningful progress — though not the final chapter. As the dialogue continues, both sides appear open to crafting a system that better aligns with science, state law, and professional sport’s evolving culture.